Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Casein kinase 2 alpha (CK2α) is the catalytic subunit of casein kinase II, a highly conserved and ubiquitously expressed serine/threonine protein kinase. It plays a central role in multiple cellular processes including cell growth, proliferation, apoptosis suppression, cell cycle regulation, DNA damage repair, and stress signaling. Overexpression or dysregulation of CK2α is associated with various cancers, making it a target for therapeutic intervention.
Inhibition of CK2α kinase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Casein Kinase II Alpha (CK2α).